Laura L. Want

Glucose Metabolism and Regulation: Beyond Insulin and Glucagon

Stephen Aronoff, Kathy J. Berkowitz, Barb Shreiner et al. · Diabetes Spectrum · 2004 · 566 citations

Metabolic Syndrome, Insulin Signaling, Diabetes Management +14

Impact of Pramlintide on Glucose Fluctuations and Postprandial Glucose, Glucagon, and Triglyceride Excursions Among Patients With Type 1 Diabetes Intensively Treated With Insulin Pumps

Claresa Levetan, Laura L. Want, Christian Weyer et al. · Diabetes Care · 2003 · 154 citations · Full text

Adjunctive Therapy with the Amylin Analogue Pramlintide Leads to a Combined Improvement in Glycemic and Weight Control in Insulin-Treated Subjects with Type 2 Diabetes

Robert E. Ratner, Laura L. Want, Mark Fineman et al. · Diabetes Technology & Therapeutics · 2002 · 154 citations